Literature DB >> 17349566

Changing trends in the distribution of the histologic types of lung cancer: a review of 4,439 cases.

Mary Wahbah1, Nahal Boroumand, Claudia Castro, Faten El-Zeky, Mahmoud Eltorky.   

Abstract

Lung cancer is the second most common cancer and the leading cause of cancer death in both men and women. The purpose of the study is to explore the distribution of the 4 major histologic types of lung carcinoma and the incidence of lung cancer with reference to all other sites of cancer. The clinical and histopathologic data of 4,439 patients with lung carcinoma between January 1980 and December 2003 were reviewed. Adenocarcinoma has become the most frequent histologic type in men and women (36.8% and 46.5%, respectively), followed by squamous cell carcinoma (31.6% and 25.4%, respectively). The incidence of large cell (undifferentiated) carcinoma in men and women is 18.0% and 9.9%, respectively. The incidence of small cell carcinoma in men and women is 13.7% and 18.3%, respectively. In addition, analysis of our data indicates that lung cancer rate is decreasing, relative to all other primary cancer sites. The results of this study suggest that the incidence of lung cancer has decreased in comparison with other sources of cancer in southern Texas. This observation is consistent with the current national trends. In addition, there are significant changes in the distribution of the major histologic types of lung cancer. The results of this study may portend important changes in the selection of targeted therapy and patient management.

Entities:  

Mesh:

Year:  2007        PMID: 17349566     DOI: 10.1016/j.anndiagpath.2006.04.006

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  31 in total

1.  Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer.

Authors:  Dung-Tsa Chen; Ying-Lin Hsu; William J Fulp; Domenico Coppola; Eric B Haura; Timothy J Yeatman; W Douglas Cress
Journal:  J Natl Cancer Inst       Date:  2011-12-08       Impact factor: 13.506

Review 2.  Reclassification of early stage pulmonary adenocarcinoma and its consequences.

Authors:  Annikka Weissferdt; Cesar A Moran
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

3.  Clinicopathologic characteristics of ALK rearrangements in primary lung adenocarcinoma with identified EGFR and KRAS status.

Authors:  Jinghui Wang; Yujie Dong; Yiran Cai; Lijuan Zhou; Shafei Wu; Guimei Liu; Dan Su; Xi Li; Na Qin; Jingying Nong; Hongyan Jia; Quan Zhang; Jing Mu; Xuan Zeng; Haiqing Zhang; Shucai Zhang; Zongde Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2014-01-18       Impact factor: 4.553

4.  Preneoplasia of lung cancer.

Authors:  Adi F Gazdar; Elisabeth Brambilla
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

5.  Cancer Progress and Priorities: Lung Cancer.

Authors:  Matthew B Schabath; Michele L Cote
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10       Impact factor: 4.254

6.  Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.

Authors:  Ahmad A Tarhini; Imran Rafique; Theofanis Floros; Phu Tran; William E Gooding; Liza C Villaruz; Timothy F Burns; David M Friedland; Daniel P Petro; Mariya Farooqui; Jose Gomez-Garcia; Autumn Gaither-Davis; Sanja Dacic; Athanassios Argiris; Mark A Socinski; Laura P Stabile; Jill M Siegfried
Journal:  Cancer       Date:  2017-05-04       Impact factor: 6.860

7.  Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for Chinese patients with squamous cell carcinoma of lung harboring EGFR mutation.

Authors:  Wenfeng Fang; Jianwei Zhang; Wenhua Liang; Yan Huang; Yue Yan; Xuan Wu; Zhihuang Hu; Yuxiang Ma; Hongyun Zhao; Yuanyuan Zhao; Yunpeng Yang; Cong Xue; Jing Zhang; Li Zhang
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

Review 8.  Role of HGF/MET axis in resistance of lung cancer to contemporary management.

Authors:  Kanwal Pratap Singh Raghav; Ana Maria Gonzalez-Angulo; George R Blumenschein
Journal:  Transl Lung Cancer Res       Date:  2012-09

Review 9.  Cholinergic Targets in Lung Cancer.

Authors:  Eliot R Spindel
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

10.  Histological subtypes of lung cancer in Chinese women from 2000 to 2012.

Authors:  Xiao Nong Zou; Dongmei Lin; Ann Chao; Xia Wan; Qinfu Feng; Junling Li; Jie Yang; Gong Huan Yang; Ning Lv
Journal:  Thorac Cancer       Date:  2014-08-25       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.